OBJECTIVE: To quantify the adverse events (AE) associated with mycophenolate mofetil (MMF)
in patients with systemic lupus erythematosus (SLE), to examine the relationship …

Objective Concern exists that medications used to treat patients with systemic juvenile idiopathic
arthritis (JIA), particularly interleukin (IL)‐1 and IL‐6 blocking agents, might be causing …

Background Non-criteria antiphospholipid antibodies (NC-aPL) are a relatively undefined
subgroup of antiphospholipid antibodies (aPL). Knowledge about NC-aPL in adults is limited …

This study describes a cohort of patients presenting with histocompatibility leukocyte antigen
(HLA)-A29-associated retinal vasculitis without choroidal lesions that may share clinical …

Background Documentation of critical data elements is a focus of the Pediatric Rheumatology
Care and Outcomes Improvement Network to aid in clinical care and research for patients …

Practice Gap: Timely and accurate recognition of collagen vascular disorders (CVDs), and
implementation of effective screening and referral processes for patients suspected of having …

Our paediatric rheumatology clinic has experienced inefficient patient flow. Our aim was to
reduce mean wait time and minimise variation for patients. Baseline data showed that most …

Background: Documentation of critical data elements is a focus of the Pediatric Rheumatology
Care and Outcomes Improvement Network to aid in clinical care and research for patients …

Objective To investigate the characteristics and risk factors of a novel parenchymal lung
disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA). Methods In a …

Objective Systemic juvenile idiopathic arthritis–associated lung disease (SJIA‐LD) is a life‐threatening
disease complication. Key questions remain regarding clinical course and …